BioDelivery Sciences Reports Strong Q2 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
BioDelivery Sciences (BDSI) Reports Q2 EPS of $0.01
August 5, 2020 7:48 AM EDTBioDelivery Sciences (NASDAQ: BDSI) reported Q2 EPS of $0.01, versus ($0.13) reported last year. Revenue for the quarter came in at $36.6 million, versus $29.7 million reported last year.
For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.
... More